Pharmacia Gives $3.15 Million Grant to NCCN to Advance Innovative Cancer Research Collaboration

-- NCCN to study clinical applications of therapies in treatment of breast, gynecological, and other forms of cancer -- [PEAPACK, NJ] – Pharmacia Corporation today announced it has provided a $3.15 million grant to the National Comprehensive Cancer Network (NCCN) for the development and review of clinical oncology research protocols and trials in breast, gynecological and other forms of cancer. The grant will provide funding for clinical research to identify treatment advances that improve p...
Source: National Comprehensive Cancer Network Oncology Research Program - Category: Cancer & Oncology Source Type: news